These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38327164)

  • 1. Non-vitamin K oral anticoagulants versus warfarin for the treatment of left ventricular thrombus.
    Kam KKH; Chan JSK; Lee APW
    Hong Kong Med J; 2024 Feb; 30(1):10-15. PubMed ID: 38327164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction.
    Zhang Z; Si D; Zhang Q; Qu M; Yu M; Jiang Z; Li D; Yang P; Zhang W
    Heart Vessels; 2022 Mar; 37(3):374-384. PubMed ID: 34420077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and outcomes in patients with left ventricular thrombus - experiences from the Aga Khan University Hospital, Nairobi - Kenya.
    Varwani MH; Shah J; Ngunga M; Jeilan M
    Pan Afr Med J; 2021; 39():212. PubMed ID: 34630824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Oral Anticoagulants Versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombus: An Updated Meta-Analysis of Cohort Studies and Randomized Controlled Trials.
    Chen Y; Zhu M; Wang K; Xu Q; Ma J
    J Cardiovasc Pharmacol; 2022 Jun; 79(6):935-940. PubMed ID: 35383658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure.
    Chen Y; Zhang Y; Qu L; Huang W; Su X; Chen Y
    J Thromb Thrombolysis; 2021 Oct; 52(3):872-879. PubMed ID: 33666825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin vs non-vitamin K oral anticoagulants for left atrial appendage thrombus: A meta-analysis.
    Murtaza G; Turagam MK; Atti V; Garg J; Boda U; Velagapudi P; Akella K; Natale A; Gopinathannair R; Lakkireddy D
    J Cardiovasc Electrophysiol; 2020 Jul; 31(7):1822-1827. PubMed ID: 32323386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Real-world Experience of the Safety and Efficacy of Non-vitamin K Oral Anticoagulants Versus Warfarin in Patients with Non-valvular Atrial Fibrillation-A Single-centre Retrospective Cohort Study in Singapore.
    Tiew WJ; Wong VL; Tan VH; Tan YC; Lee EM
    Ann Acad Med Singap; 2020 Nov; 49(11):838-847. PubMed ID: 33381777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.
    Hussain A; Katz WE; Genuardi MV; Bhonsale A; Jain SK; Kancharla K; Saba S; Shalaby AA; Voigt AH; Wang NC
    Pacing Clin Electrophysiol; 2019 Sep; 42(9):1183-1190. PubMed ID: 31355470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.
    Wu S; Xie S; Xu Y; Que D; Yau TO; Wang L; Huang Y
    J Clin Nurs; 2019 May; 28(9-10):1839-1846. PubMed ID: 30667111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombus: A Systematic Review and Meta-analysis.
    Burmeister C; Beran A; Mhanna M; Ghazaleh S; Tomcho JC; Maqsood A; Sajdeya O; Assaly R
    Am J Ther; 2021 Apr; 28(4):e411-e419. PubMed ID: 33852473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes.
    Kim SE; Lee CJ; Oh J; Kang SM
    ESC Heart Fail; 2023 Jun; 10(3):1987-1995. PubMed ID: 37009745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data.
    Kohsaka S; Katada J; Saito K; Jenkins A; Li B; Mardekian J; Terayama Y
    Open Heart; 2020; 7(1):e001232. PubMed ID: 32341789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function.
    Lee SR; Choi EK; Han KD; Jung JH; Cha MJ; Oh S; Lip GYH
    Stroke; 2019 Jun; 50(6):1480-1489. PubMed ID: 31084339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis.
    Li Z; Zheng Y; Li D; Wang X; Cheng S; Luo X; Wen A
    Anatol J Cardiol; 2022 Jun; 26(6):424-433. PubMed ID: 35703478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness and safety of non-vitamin-K antagonist oral anticoagulants and warfarin in older adults with atrial fibrillation and diabetes.
    Korgaonkar S; Yang Y; Banahan B; Bentley JP
    Curr Med Res Opin; 2021 Mar; 37(3):343-356. PubMed ID: 33327796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus After Acute Anterior Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Intervention.
    Liang J; Wang Z; Zhou Y; Shen H; Chai M; Ma X; Han H; Shao Q; Li Q
    Curr Vasc Pharmacol; 2022; 20(6):517-526. PubMed ID: 36200193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System.
    von Lueder TG; Atar D; Agewall S; Jensen JK; Hopper I; Kotecha D; Mentz RJ; Kim MH; Serebruany VL
    Am J Ther; 2019; 26(6):e671-e678. PubMed ID: 31145139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis.
    Bang OY; On YK; Lee MY; Jang SW; Han S; Han S; Won MM; Park YJ; Lee JM; Choi HY; Kang S; Suh HS; Kim YH
    PLoS One; 2020; 15(11):e0242922. PubMed ID: 33253294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation and valvular heart disease.
    Li HJ; Lin SY; Lin FJ; Hung CS; Wang CC
    Curr Med Res Opin; 2021 Apr; 37(4):535-542. PubMed ID: 33538623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.